Abstract: The present invention is a process and apparatus for forming various bio-products from cellulosic plant material. The plant material is subjected to a pulping step in which lignin is extracted from the material by an aqueous lignin solvent to form a lignin-solvent mixture and purified cellulose. The lignin-solvent mixture can be separated from the water to form a high energy density fuel that can be used independently or combined with biodiesel. The purified cellulose can be used in conventional processes, e.g., paper making, or can be converted to fermentable sugars with a cellulase enzyme to produce other bio-products depending on the operating conditions of the fermenter. The bio-products produced by the fermenter can include the solvent that may be recycled for use in extracting the lignin.

Abstract: An electronic message transport protocol applies two distinct sub-protocols, a message transport protocol and an encryption key management protocol, which operate in tandem to provide enhanced security. The protocol may employ an existing SMTP infrastructure to transport secure email messages, and a key server implementing the key management protocol to transport key packets associated with the secure email message. However, the protocol need not be limited to email, and may be applicable to other electronic message applications. The message transport protocol permits communicating parties to obscure their identities to enhance security. The key management protocol supports message security, and allows senders to control access to messages even after they have been transmitted. The message transport protocol permits the sender to encrypt the entire message and utilizes the key management protocol for exchange of necessary keys.

Abstract: A food transfer platform incorporating a stove unit elevates to different heights, by an extendible column, and can move along a floor.

Abstract: The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.

Abstract: The present invention provides molecules and methods for fluorescent microscopy and visualization of biomolecules, such as cholesterol. In a preferred embodiment, the present invention provides a compound having the structure: wherein R1 and R2 are selected from the group consisting of H, CnH2n+1, (CH2)mNH2, (CH2)mNH—SO2—R?, and CH2CH2OCH2CH2NH2 wherein n has a value between 4 and 18, wherein m has a value between 2 and 8, and wherein R? is selected from the group consisting of CH3, C6H5, C6H4CH3, C6H4CO2H and its cyclic imide, C6H4Br, anthraquinon-2-yl, and 5-formyl-2-furyl, 2-carboxyphenyl.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: Linear arrays of chemosensors or chemical compounds are supported by an optical fiber that allows one to rapidly assay the entire array using changes in optical properties such as fluorescence. The location of the agent along the fiber determines the identity of the agent in these linear arrays. Combinatorial libraries may be constructed on the fiber as well as assayed on the optical fiber. A system and method of analyzing the entire array of agents on an optical fiber using a light source, an optical fiber, and a detector are also described. The time delay between the excitation and detection determines the location being assayed along the fiber and therefore the identity of the agent being assayed. The present invention may find uses in the medical, pharmaceutical, environmental, defense, and food industries.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: An apparatus for and method of conducting a nerve conduction study is provided. In response to predetermined stimulation from an excitation device, a signal is generated that travels through a human body. The apparatus includes a sensing electrode operatively engagable with the human body downstream of the excitation device for sensing the signal. The apparatus further includes a pressure mounting structure operatively connected to the sensing electrode for controlling the pressure at which the sensing electrode engages the body. The pressure mounting structure includes a pressure source and a pressure sensor. A controller receives a pressure signal from the pressure sensor and the signal from the sensor electrode. The controller includes software to normalize the amplitude of the signal based on the pressure at which the sensing electrode engages the body.

Abstract: The present invention provides molecules and methods for the prevention and/or treatment of memory deficit related conditions and/or enhancement of cognizance. In a preferred embodiment, the invention includes compounds, salts and prodrugs thereof for the prevention and/or treatment of these conditions.

Abstract: A composition and method for forming investment casting shells includes using colloidal silica, zircon flour, and fused silica in a slurry which is applied to a pattern. After the slurry is applied to the pattern, it is allowed to partially or completely solidify. After the shell has solidified, the pattern may be melted or otherwise removed. A molten material is introduced into the shell and allowed to cool to form an article. Finally, the shell is broken away or otherwise removed from the article. The improved shell slurry composition and corresponding method minimizes pattern-to-pour cycle times and is environmentally friendly.

Abstract: Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.

Abstract: The present invention provides molecules and methods for fluorescent microscopy and visualization of biomolecules, such as cholesterol. In a preferred embodiment, the present invention provides a compound having the structure: wherein R1 and R2 are selected from the group consisting of H, CnH2n+1, (CH2)mNH2, (CH2)mNH—SO2—R?, and CH2CH2OCH2CH2NH2 wherein n has a value between 4 and 18, wherein m has a value between 2 and 8, and wherein R? is selected from the group consisting of CH3, C6H4, C6H4CH3, C6H4CO2H an its cyclic imide, C6H4Br, anthraquinon-2-yl, and 5-formyl-2-furyl, 2-carboxyphenyl.

Abstract: The present invention provides compounds and methods of using of the compounds as anti-infective agents. In a preferred embodiment, the present invention provides wherein R1 is not H when R2 is H and R2 is not H when R1 is H, further wherein R1 is CH(2n+1)O, wherein n is 1-10; wherein R2 is OH or CH(2n+1)O, wherein n is 1-10; and wherein A, B and R1, R2, R5, R6, and R7 are independently selected from a group consisting of H, alkyl and aryl groups and R11 is an alkyl or an aryl group.

Abstract: The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.

Abstract: A method of expressing proteins is disclosed. In a preferable embodiment, the method comprises placing a DNA sequence encoding a protein or peptide and expression vector containing a regulatable promoter expressible in Rhodospirillum rubrum and expressing the protein within a bacterial host, wherein the host has extra capacity for membrane formation and wherein the host is a member of the genus Rhodospirillum.

Abstract: A new and distinct cultivar of plum, similar to a Japanese-American hybrid-type originating as a hybrid seedling of the cross: ‘Oka’בZ's Blue Giant’. The present cultivar is unique from its maternal parent and other plums adapted to the Midwest Zone 3b and above, because it is similar to many California dessert plums (dark blue-black and nearly round) and with a superior ripe flavor to most common cultivars tested in its ripening season. The instant cultivar is also more dwarf in growth habit and has an earlier fruit maturity than most common midwest plums.